Paola Mosconi is a biological scientist with a post-doctoral degree in Pharmacological Research. She is involved in projects pertaining the involvement of lay people and their representativeness in health care aspects and outcome research.
Last month, Paola Mosconi and colleaguespublished in试验a report on the development of the European Communication on Research Awareness Needs (ECRAN) project and here, she answers our questions.
为什么欧洲关于研究意识需求的传播（ECRAN）项目启动了？
TheEcran项目was designed to support the strategy of the European Commission to fund independent, investigator-driven, multinational clinical trials.
Randomized clinical trials are the basis of evidence-based medicine; nevertheless, general populations do not have enough knowledge and awareness about the importance of this method. With increased knowledge and awareness, we can increase engagement in the research.
确保获得正确的信息可以鼓励外行人和患者参与研究和试验设计。即使欧盟委员会将大量资金分配给了独立，研究人员驱动的临床试验，通常仍然很困难。
Why was it important to include representatives from all stakeholders – clinicians, methodologists, researchers, patients, and science communications experts?
Clinical research is a team game, which must take advantage of multidisciplinary perspectives. In the ECRAN consortium, all stakeholders were represented and provided their insights as the project progressed and during the development of the tools and materials.
In particular, two ECRAN partners were lay representatives from theConsumer Cochrane Network和来自European AIDS Treatment Group：他们的经验为开发高质量但易于使用和简单工具提供了独特的观点。
What were the main aims for the ECRAN project?
预计开始时，在欧洲尚未协调临床试验的临床和社会益处的交流。没有关于如何宣传独立跨国临床试验的重要性的策略。
Before the ECRAN project began, what was missing was a shared package of information and tools for the general population and patients.
Before the ECRAN project began, what was missing was a shared package of information and tools for the general population and patients.
The objective of the ECRAN project was to develop a portfolio of valuable and accessible educational resources to communicate key messages to the general public, as well as healthcare professionals, researchers, policymakers and journalists.
关键信息是公众对临床试验的需求和基本原则的理解的重要性，包括需要独立临床试验。其他关键信息包括需要透明度和最佳数据使用数据，最后，需要跨国合作，以利用欧洲的人口规模，多样性和医疗专业知识。
该项目还旨在支持欧洲委员会为独立（研究人员驱动的）跨国临床试验的战略。
Ecran项目取得了什么成就？
ECRAN项目开发的所有工具和材料都共享以下教育重点：不确定性，控制措施，随机分配，结果，独立临床研究以及对跨国临床试验的需求.
所有生产的材料均受创意共享许可证，并且可以免费获得这里.
其中开发了不同的工具，其中包括五分钟的动画电影，两部
教育游戏 - Ecran Lab和Ecran迷宫，以吸引欧洲公民和学生的兴趣 - 以及在线收集所有通讯材料和工具，旨在将临床试验的重要性传达给公众。
It is very important to underline the multinational and multilingual dimension of the ECRAN project.
大多数工具和材料都有六种不同的语言，涵盖欧洲公民四分之三的语言，包括英语，法语，意大利语，西班牙语，德语和波兰语的翻译。一些工具提供23种官方语言，例如动画电影和在线数据库。
ECRAN推动的最后一项活动是致其所有欧洲教育部长，欧洲学校负责人，欧洲教师和父母的公开信和请愿书。
The letter proposes the introduction to clinical research as part of school curriculum for all European pupils for three consecutive years around the ages of 14, 15, and 16 years. For more details see这里.
Ecran项目是否有未来的计划？
该项目的一些合作伙伴也参与了工作包的开发，作为该项目的一部分Corbel project(COordinated Research Infrastructures Building Enduring Life-science Services), which aims to develop a template for informative clinical trial material and includes the ECRAN tools.
正如我们在我们的中报道的那样，确保现在可用的Ecran工具的传播和实施非常重要open letter, “A well prepared European population will make the population more open to clinical research through understanding the necessities and complexities of clinical research”.
Using these tools within current research could be an aim of a future European project.
注释